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ABSTRACT: Escherichia coli class Ia ribonucleotide reductase is
composed of two subunits (α and β), which form an α2β2 complex
that catalyzes the conversion of nucleoside 5′-diphosphates to
deoxynucleotides (dNDPs). β2 contains the essential tyrosyl
radical (Y122
•) that generates a thiyl radical (C439
•) in α2 where
dNDPs are made. This oxidation occurs over 35 Å through a
pathway of amino acid radical intermediates (Y122→ [W48]→ Y356
in β2 to Y731 → Y730 → C439 in α2). However, chemistry is
preceded by a slow protein conformational change(s) that prevents
observation of these intermediates. 2,3,5-Triﬂuorotyrosine site-
speciﬁcally inserted at position 122 of β2 (F3Y
•-β2) perturbs its
conformation and the driving force for radical propagation, while maintaining catalytic activity (1.7 s−1). Rapid freeze−quench
electron paramagnetic resonance spectroscopy and rapid chemical-quench analysis of the F3Y
•-β2, α2, CDP, and ATP (eﬀector)
reaction show generation of 0.5 equiv of Y356
• and 0.5 equiv of dCDP, both at 30 s−1. In the absence of an external reducing
system, Y356
• reduction occurs concomitant with F3Y reoxidation (0.4 s
−1) and subsequent to oxidation of all α2s. In the presence
of a reducing system, a burst of dCDP (0.4 equiv at 22 s−1) is observed prior to steady-state turnover (1.7 s−1). The [Y356
•] does
not change, consistent with rate-limiting F3Y reoxidation. The data support a mechanism where Y122
• is reduced and reoxidized on
each turnover and demonstrate for the ﬁrst time the ability of a pathway radical in an active α2β2 complex to complete the
catalytic cycle.
■ INTRODUCTION
Ribonucleotide reductases (RNRs) catalyze the formation of
deoxynucleotides from their corresponding ribonucleotides
(Scheme 1) in almost all organisms; allosteric regulation of
substrate speciﬁcity and activity contributes to ﬁdelity of both
DNA replication and repair.1,2 The class Ia RNRs contain two
homodimeric subunits, α2 and β2, which form an active α2β2
complex in the case of the E. coli enzyme.3 The β2 subunit
houses a diferric-tyrosyl radical (Y122
•) cofactor that reversibly
oxidizes C439 in the active site of α2 to a thiyl radical.
4,5 The
C439
• initiates nucleotide reduction by H atom abstraction from
the 3′ position of the substrate (Scheme 1).6,7 On the basis of
in silico docking of the individual X-ray structures of α2 and
β2,8,9 the distance between Y122
• and C439 is estimated to be
>35 Å. This radical transport (RT) process occurs through a
speciﬁc pathway that involves at least three transient aromatic
amino acid radical intermediates (proton-coupled electron
transfer or PCET through Y122
• → [W48] → Y356 in β2 to
Y731 → Y730 → C439 in α2, Figure 1).
9,10 During turnover of
wild-type (wt) RNR, only the resting state Y122
• is observed.
In this paper, we describe the perturbation of PCET kinetics
by site-speciﬁc incorporation of 2,3,5-triﬂuorotyrosine (F3Y)
at position 122 in β2 resulting in accumulation of a pathway
tyrosyl radical intermediate (Y356
•) that is kinetically and
chemically competent to complete the catalytic cycle of RNR.
In wt RNR, PCET steps are preceded by a rate-limiting
protein conformational change(s) (5−10 s−1) that occur(s)
upon association of α2, β2, substrate (S, CDP), and allosteric
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Scheme 1. Reaction Catalyzed by RNRa
aTurnover requires reducing equivalents which are provided by a pair
of cysteines in the active site of the enzyme.
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eﬀector (E, ATP).11 Forward RT steps, active site chemistry,
and reverse RT steps occur on a much more rapid time scale
than the protein conformational change(s) preventing observa-
tion of radical intermediates either during steady-state turnover
or using rapid kinetic methods.11 An approach adopted by our
lab has been to change the rate-limiting step of the reaction by
site-speciﬁcally incorporating tyrosine analogues with perturbed
pKa’s and reduction potentials in an eﬀort to accumulate and
characterize the proposed radical intermediates (Figure 1).
Previously, we described the insertion of 3-nitrotyrosine (NO2Y)
at residue 122 in β2.12 The reaction of NO2Y
•-β2, α2, CDP, and
ATP rapidly generates 0.5 equiv of Y356
• and dCDP (>100 s−1).
We have proposed that this stoichiometry is a consequence of
half-sites reactivity in RNR where only 50% of Y122
• in the α2β2
complex reacts at a time.13−17 We have recently shown that,
upon radical initiation in wt RNR, a proton is transferred from
a water molecule on the diferric cluster to generate the cor-
responding Y122 phenol (Figure 1).
18 In contrast, use of NO2Y
•-
β2 to initiate RT uncouples this proton transfer (PT) and
electron transfer (ET); the conjugate base NO2Y
− is generated
instead of the anticipated phenol NO2Y. Furthermore, Y356
•
generated during reverse RT is unable to reoxidize NO2Y
−, and
thus, this mutant could only perform a single turnover.12 This
prevented us from establishing the chemical competence of Y356
•
to complete the catalytic cycle and determining if it is a true
intermediate on the PCET pathway.
In an attempt to engineer a smaller perturbation to the driving
force, we inserted F3Y at position 122 in β2 and investigated the
reaction of F3Y
•-β2, α2, CDP, and ATP.19 Steady-state assays
revealed that, unlike the NO2Y
•-β2 mutant, F3Y
•-β2 can catalyze
multiple turnovers at 25% the steady-state wt activity. Hand-
quench EPR experiments showed formation of a new tyrosyl
radical, assigned to residue Y356 in β2 based on multiple lines of
evidence. First, the new radical is observed when the redox inert
F is inserted at position 731 but not at position 356.19 Second,
the 9 GHz EPR spectrum of the new radical is remarkably similar
to that of the radical observed in the NO2Y
•-β2 studies.12,19
In NO2Y
•-β2, pulsed electron−electron double resonance
(PELDOR) spectroscopy experiments measured a distance of
30 Å between the new radical in one α/β pair and NO2Y
• in the
second α/β pair.20 Similar experiments with other un-natural
amino acids inserted at position 356 (either 3,4-dihydroxyphe-
nylalanine21 or 3-aminotyrosine22) provide an identical distance
measurement (30 Å). In preliminary PELDOR experiments,
a similar distance is also observed between F3Y
• and the new
radical (Nick, Bennati, unpublished results). These data together
support that the radical observed in F3Y
•-β2 is located at posi-
tion 356. Studies with NO2Y
•-β2, however, have shown that while
the predominant location of the radical is at position 356
(85−90%), Y356• is in equilibrium with Y731• and Y730• in α2
(15−10%).20 These initial studies laid the foundation for the work
described herein and gave us an opportunity to investigate the
importance of Y356
• and reverse RT in an active RNR complex.
In this work, we carry out thorough kinetic analyses of the
reaction of F3Y
•-β2, α2, CDP, and ATP in the absence and pre-
sence of an external reducing system composed of thioredoxin
(TR), thioredoxin reductase (TRR), and NADPH. Rapid
freeze−quench (RFQ) EPR spectroscopy and rapid chemical-
quench (RCQ) studies in the absence of a reducing system
demonstrate that Y356
• is kinetically and chemically competent;
similar amounts of Y356
• and dCDP are produced at similar
rate constants. Furthermore, subsequent to complete oxidation
of α2, Y356
• reduction occurs concomitant with F3Y reoxidation.
RCQ analysis in the presence of a reducing system shows
a burst of dCDP prior to steady-state turnover suggesting that
the rate-limiting step occurs after product formation. EPR
studies detect no changes in Y356
• concentration during steady-
state turnover. Together, the data support the conclusion that
reverse RT within β2 leading to regeneration of F3Y
• is rate-
limiting during steady-state turnover of F3Y
•-β2.
■ MATERIALS AND METHODS
Materials. (His)6 wt-α2 (speciﬁc activity of 2500 nmol/min/mg)
was expressed from pET28a-nrdA and puriﬁed using our standard
protocol.23 Wt-α2 was pre-reduced by the addition of DTT and hydro-
xyurea prior to use.24 Tyrosine phenol lyase (TPL) was expressed
and puriﬁed as described.25 F3Y was enzymatically synthesized from
the corresponding phenol using TPL.26 The pBAD-nrdB122TAG and
pEVOL-FnYRS-E3 plasmids were generated and isolated as de-
scribed.19 Apo F3Y-β2 was expressed, puriﬁed, and reconstituted as
detailed in the Supporting Information (SI). Yields of 10−15 mg of pure
apo protein/g cell paste are routinely obtained. Reconstituted F3Y
•-β2
has a speciﬁc activity (750−1000 nmol/min/mg) that varies directly
with the radical content (0.6−0.8 F3Y•/β2). E. coli TR (40 U/mg) and
TRR (1400 U/mg) were puriﬁed using established protocols.27,28 [3H]
CDP was purchased from ViTrax (Placentia, CA). Hepes, MgSO4,
EDTA, 2XYT microbial medium, ampicillin (Amp), chloramphenicol
(Cm), ATP, CDP, and carrier deoxycytidine (dC) were obtained from
Sigma-Aldrich. Promega provided isopropyl β-D-1-thiogalactopyranoside
(IPTG) and DTT. Calf alkaline phosphatase was purchased from Roche.
Assay buﬀer consists of 50 mM Hepes pH 7.6, 15 mM MgSO4, and
1 mM EDTA.
Figure 1. Proposed PCET pathway in E. coli class Ia RNR.10 The pink and blue arrows indicate the movement of electrons and protons through
conserved aromatic amino acids (Y356 in β2 and Y731 and Y730 in α2). W48 and its putative proton acceptor D237 are shown in gray, as there is no
evidence for their participation in RT. The positions of Y356 and E350 are unknown, as these residues are disordered in all crystal structures of β2.
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Reaction of F3Y
•-β2, wt-α2, CDP, and ATP Monitored by
RFQ-EPR Spectroscopy. RFQ experiments were performed on an
Update Instruments 1019 syringe ram unit and a model 715 Syringe
Ram controller (ram speed 1.25−1.6 cm/s) equipped with a Lauda
RM6 circulating water bath set at 5 or 25 °C. F3Y
•-β2 (0.4−0.8 F3Y•/β2,
80 μM) and CDP (2 mM) in assay buﬀer was mixed on a rapid time
scale (16 ms−15 s) with an equal volume of wt-α2 (80 μM) and ATP
(6 mM) in assay buﬀer. The reaction was quenched in liquid isopentane
(−140 °C), and the crystals were packed into EPR tubes for analysis
by EPR spectroscopy. A packing factor of 0.60 ± 0.02 was determined
for wt-β2. The reaction at 5 °C was additionally monitored on a longer
time scale (20 s−2 min) by mixing all assay ingredients by hand (30 μM
wt-α2, 30 μM F3Y
•-β2, 1 mM CDP, and 3 mM ATP) and quenching in
liquid isopentane. EPR spectroscopy was performed at the Department
of Chemistry Instrumentation Facility at MIT using wt-β2 (1.2 Y•/β2)
as a standard. The concentration of Y• in the wt-β2 standard was
previously estimated using a Cu(II)SO4 standard.
29 EPR spectra were
recorded at 77 K on a Bruker EMX X-band spectrometer with a quartz
ﬁnger dewar containing liquid N2. The parameters were as follows:
microwave frequency 9.45 GHz, power 30 μW, modulation amplitude
1.50 G, modulation frequency 100 kHz, time constant 5.12 ms, and
scan time 41.93 s. From each composite spectrum, residual F3Y
• was
subtracted by aligning the radical’s distinct features on the high- and
low-ﬁeld sides of the spectrum as previously reported (Figure S1).19
The subtracted spectrum was reintegrated to quantitate the percentage
of any observed pathway radical. The complete data sets at 5 and 25 °C
were ﬁt to eq 1:
= − + −− −y A A(1 e ) (1 e )k t k t1 21 2 (1)
where A1 and A2 are the amplitudes of the two phases and k1 and k2 are
the observed rate constants.
Reaction of F3Y
•-β2, wt-α2, CDP, and ATP Monitored by the
RCQ Method. RCQ experiments were performed on a KinTek
RQF-3 instrument equipped with a Lauda RM6 circulating water
bath set at 5 or 25 °C. Syringe A containing 20 μM wt-α2 and 6 mM
ATP in assay buﬀer was mixed with an equal volume from syringe B
containing 20 μM F3Y
•-β2 (0.85 F3Y
•/β2) and 1 mM [3H] CDP
(22 000 cpm/nmol) in assay buﬀer. The reaction was aged for varying
times (5 ms−100 s) and quenched with 2% HClO4 in syringe C. The
reaction was additionally monitored at >100 s by mixing the contents
of the two syringes by hand, incubating the reaction mixture in a
circulating water bath for the desired period of time, and manually
quenching the reaction with 2% HClO4. All samples were neutralized
by the addition of 110−160 μL of 0.5 M KOH and worked up as
described.11,30 For the measurement of radioactive background from
[3H] CDP, an equal volume of the contents of syringe B was mixed
with assay buﬀer, followed by 2% HClO4 and KOH. The reaction was
also performed by hand (100 s at 5 or 25 °C) before and after the
entire RCQ time course to account for any air oxidation of wt-α2. The
5 °C data set was ﬁt to eq 1, and the 25 °C data set was ﬁt to eq 2:
= − + − +− −y A k t0.50(1 e ) (1 e )t k t30 2 32 (2)
In eq 2, the ﬁrst phase is ﬁxed, A2 and k2 represent the amplitude and
rate constant of the second phase, and k3 represents the rate constant
for the third phase.
Reaction of F3Y
•-β2, wt-α2, CDP, ATP, TR/TRR/NADPH
Monitored by Hand-Quench EPR Spectroscopy. Reactions were
performed in a total volume of 250 μL containing 10 μM wt-α2,
10 μM F3Y
•-β2 (0.6 F3Y
•/β2), 1 mM CDP, 3 mM ATP, 40 μM TR,
0.8 μM TRR, and 1 mM NADPH in assay buﬀer. Samples were
incubated in a circulating water bath set at 5 °C and quenched for EPR
analysis between 20 and 90 s in liquid isopentane (−140 °C). The
reactions were also performed at 25 °C in a ﬁnal volume of 250 μL
containing 30 μM wt-α2, 10 μM F3Y
•-β2 (0.6 F3Y
•/β2), 2.5 mM
CDP, 3 mM ATP, 80 μM TR, 1.6 μM TRR, and 2.5 mM NADPH.
Reaction of F3Y
•-β2, wt-α2, CDP, ATP, and TR/TRR/NADPH
Monitored by the RCQ Method. The reaction was performed in an
identical fashion to that described in the absence of a reducing system
with minor modiﬁcations. For data collected at 5 °C, syringe A contained
20 μM wt-α2, 6 mM ATP, 80 μM TR, and 1.6 μM TRR in assay buﬀer,
while syringe B contained 20 μM F3Y
•-β2 (0.6 F3Y
•/β2), 1 mM [3H]
CDP (20 000 cpm/nmol), and 2 mM NADPH. For the 25 °C reaction,
the amount of [3H] CDP in syringe B was increased to 2 mM. Samples
were quenched and worked up as described earlier. The time courses of
the reactions were ﬁt to eq 3:
= − +−y A k t(1 e )k t 21 (3)
Here A and k1 are the amplitude and rate constant for the burst phase,
respectively, and k2 is the rate constant for the linear phase.
■ RESULTS
“Two or None” Radical Distribution and Half-Sites
Reactivity in F3Y
•-β2. The diferric-F3Y
• cofactor is self-
assembled from apo F3Y-β2 by the addition of Fe
2+ and O2 to
produce ∼0.8 F3Y•/β2 (SI), lower than the 1.2 Y•/wt-β2.31
While the radical distribution in β2 has remained diﬃcult to
probe experimentally, evidence collected over the past few years
supports that active β2 contains one Y• in each monomer (“two
or none”, Figure 2A), suggesting that only ∼40% of β2 is active
in our F3Y
•-β2 samples.12,13,20−22,32,33 To provide support for
this conclusion, we monitored the eﬀect of F3Y
• concentration
on the amount of Y356
• that accumulates. RFQ-EPR experiments
were performed at 25 °C with F3Y
•-β2 containing 0.4 F3Y
•/β2
or 0.85 F3Y
•/β2, wt-α2, CDP, and ATP. The kinetic analysis
of these studies is discussed subsequently, but the amount of
Y356
• is 0.43 and 0.5 equiv/F3Y
•, respectively (Table S1). This
amount can be rationalized by the “two or none” radical
distribution model (Figure 2A) as well as half-sites reactivity
in RNR (Figure 2B); only one of the 2 F3Y
• reacts at a time to
generate Y356
•.20−22
Kinetics in the Absence of a Reducing System. Kinetics
of Formation and Disappearance of Y356
• at 25 °C. To assess
if Y356
• is formed faster than the turnover number of
the enzyme (1.7 s−1, Table 1), a RFQ-EPR experiment was
performed in which wt-α2, F3Y
•-β2, CDP, and ATP were
mixed rapidly (16 ms to 15 s). EPR analysis of each sample
revealed a mixture of F3Y
• and Y356
•, and spectral subtractions
Figure 2. (A) “Two or none” model for radical distribution in F3Y
•-β2.
The amounts of active (40%) and inactive β2 (60%) are shown for a
sample containing 0.8 F3Y
•. The amount of radical in F3Y
•-β2 is lower
than that typically seen in wt-β2 (1.2 Y•/β2).31 (B) Half-sites reactivity
in F3Y
•-β2. The total amount of Y356
• that can accumulate on one
turnover is 0.5 equiv/F3Y
•.
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were performed to quantitate the relative fraction of each
radical. The unique hyperﬁne interactions associated with the
ﬂuorine nuclei facilitated spectral deconvolution (Figure S1).19
The results of the experiment are shown in Figure 3A, and the
data were ﬁt to a biexponential equation. Rapid loss of 0.51 ±
0.02 equiv of F3Y
• (not shown) concomitant with formation of
identical amounts of Y356
• occurs at 30 ± 5 s−1. Subsequently,
reduction of the pathway radical with kapp 0.4 ± 0.1 s
−1 is
accompanied by reformation of F3Y
• with the same kapp (not
shown). These data show for the ﬁrst time, accumulation of a
pathway radical (Y356
•) in an active RNR complex that can
regenerate the stable radical at position 122 (F3Y
•). We note that
between 0.1 and 1 s, the concentration of Y356
• varies minimally.
As shown subsequently, F3Y
•-β2 can make multiple dCDPs in
the absence of a reducing system, and the reduction of Y356
• and
reoxidation of F3Y are only visualized after the last turnover when
all α2s are oxidized. Finally, regeneration of F3Y
• is incomplete
with only 0.25 equiv of Y356
• reoxidizing F3Y within 10 s.
Kinetics of Formation and Disappearance of Y356
• at 5 °C.
The rapid formation of Y356
• at 25 °C resulted in generation of
0.25 equiv (50% of total Y356
•) prior to the ﬁrst data point (16 ms,
Figure 3A) prompting us to switch to lower temperatures to slow
down the reaction. RFQ-EPR experiments were set up at 5 °C
as described for 25 °C, and the results are shown in Figure 4A.
Table 1. DeoxyCDP Formation Kinetics in the Absence and Presence of TR/TRR/NADPHa
ﬁrst phase second phase total dC
β2 T (°C) R k1 (s
−1) A/radical k2 (s
−1) A/radical dC/α2 dC/radical
F3Y 25 N 30
b 0.5b 0.5 (1) 2.9 (1) 2.8 (4)c 3.5 (3)c
F3Y 25 Y 22 (9) 0.40 (5) 1.73 (4)
F3Y 5 N 3 (1) 0.3 (1) 0.08 (1) 2.9 (1) 2.7 (1) 3.4 (1)
F3Y 5 Y 6 (3) 0.26 (5) 0.20 (1)
aAll experiments were performed with 10 μM wt-α2 and 10 μM F3Y
•-β2. R notes the absence or presence of a reducing system. A represents the
amplitude of each phase. bSee description in main text and SI for more details regarding ﬁtting. cNumbers reported reﬂect the total amount of dC
generated within the ﬁrst two phases. Product generated in the third phase is cytosine.
Figure 3. Reaction of F3Y
•-β2, wt-α2, CDP, and ATP at 25 °C monitored by (A) RFQ-EPR spectroscopy and (B) the RCQ method. All data points
represent the averages of two independent trials. Data were ﬁt to a (A) two- or (B) three-phase model with the rate constants shown in Table 1. (B)
The inset shows dCDP formation during the ﬁrst 2 s of the reaction. The rate constants measured for Y356
• formation and disappearance correlate
with the ﬁtted rate constants for dCDP formation in the ﬁrst two phases.
Figure 4. Reaction of F3Y
•-β2, wt-α2, CDP, and ATP at 5 °C monitored by (A) RFQ-EPR spectroscopy and (B) the RCQ method. All data points
represent the averages of two independent trials. Black lines represent biexponential ﬁts to the data with the rate constants given in Table 1. (B) The
inset shows dCDP formation during the ﬁrst 5 s of the reaction. The rate constants measured for Y356
• formation and disappearance are identical to
the rate constants measured for dCDP formation.
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A kapp of 3.8 ± 0.5 s
−1 was measured for formation of Y356
•
concomitant with loss of F3Y
• (not shown). In contrast to our
observation at 25 °C, only 0.32 ± 0.02 equiv of Y356
• is formed
at 5 °C reﬂecting temperature dependent changes in the rates
of formation and decay of the pathway radical. Similar to our
observation at 25 °C, the concentration of Y356
• varies minimally
between 0.8 and 5 s supporting the proposal that F3Y
•-β2
catalyzes multiple turnovers prior to visualization of reverse
RT. Unlike in the 25 °C reaction, Y356
• reduction at 5 °C is
accompanied by complete reformation of F3Y
• (0.3 equiv,
0.06 ± 0.01 s−1) within ∼40 s.
Kinetics and dCDP Formation with F3Y
•-β2 at 25 °C. Each
dCDP generated by RNR is accompanied by the forma-
tion of a disulﬁde bond in the active site of an α monomer
(Scheme 1, Figure 5, step A). Re-reduction of the active site
disulﬁde by a C-terminal cysteine pair on each monomer (step B)
facilitates an additional turnover (step C),11 giving a theoretical
maximum of 4 dCDP/α2 in the absence of TR/TRR/NADPH.
In practice, only 3 dCDP/α2 are routinely measured with wt
RNR due to partial oxidation of α2 (during puriﬁcation and
handling) and our inability to completely pre-reduce wt-α2 before
an experiment.11 Our kinetic experiments with F3Y
•-β2 contain
1:1 α2:F3Y
•-β2 with only 40% of active F3Y
•-β2 (Figure 2A).
However, 3 dCDP/α2 are generated in the absence of a reducing
system (Table 1) requiring that each F3Y
• perform multiple
turnovers (3.5 dCDP/F3Y
•, Table 1) to service all α2s.
To assess if Y356
• is on-pathway, the kinetics of dCDP
formation were determined. Wt-α2, F3Y
•-β2, [3H] CDP, and
ATP were mixed (5 ms to 300 s) and quenched rapidly with
2% HClO4. CDP and dCDP were separated and analyzed by
standard procedures,11,30 and the results are shown in Figure 3B.
The data are best described by eq 2 with a ﬁxed ﬁrst exponential
phase, a variable second exponential phase, and a very slow third
linear phase. We initially attempted to ﬁt the data with an
exponential phase and a linear phase with poor results (Figure S2A).
To obtain the ﬁt shown in Figure 3B (black line), we ﬁxed the
amplitude and rate constant (k1) of the ﬁrst phase at 0.5 dCDP/
F3Y
• and 30 s−1, respectively. Fixing this phase was required due
to the scatter in the data at early time points. This scatter is a
result of “two or none” and half-sites reactivity associated with
RNR (Figure 2A,B). The [3H] dCDP measured between 5 and
100 ms is close to the background measured with [3H] CDP in the
absence of α2. The range of choices considered for the amplitude
and k1 of this phase were based on the amplitude and rate constant
measured for Y356
• formation by RFQ-EPR (Figure 3A) and
the results obtained in the presence of the reducing system
(presented in the next section). The detailed description of data
ﬁtting using diﬀerent parameters for the ﬁrst kinetic phase is
shown in Figure S2A−D. An additional experiment to justify the
ﬁxed ﬁrst phase is shown in Figure S3.
Once the ﬁrst phase was ﬁxed using eq 2, we obtained an
amplitude and rate constant (k2) of 2.9 ± 0.1 dCDP/F3Y
• and
0.5 ± 0.1 s−1, respectively, for the second phase and a rate
constant (k3) of 0.012 ± 0.001 s
−1 for the linear phase. This
slow linear phase is associated with cytosine release and not
dCDP formation. It occurs during the reaction of F3Y
•-β2 with
oxidized α2 as shown in Scheme S1.34 In a second manuscript,
we show that the inability to monitor complete reverse RT
at 25 °C (Figure 3A) is associated with reoxidation of Y356
(0.25 equiv) by F3Y
•-β2/oxidized α2.
The ﬁt shown in Figure 3B suggests that the pathway radical
is kinetically and chemically competent for nucleotide reduc-
tion at 25 °C. These data require that Y356
• accumulates during
reverse RT. k2 for product formation correlates well with kapp
for Y356
• disappearance at this temperature (0.5 s−1 vs 0.4 s−1,
Figure 3A).
Kinetics and dCDP Formation with F3Y
•-β2 at 5 °C.
The kinetics of dCDP formation were also measured at 5 °C,
and the results are shown in Figure 4B. The data were ﬁt to a bi-
exponential equation providing amplitudes of 0.3 ± 0.1 dCDP/
F3Y
• and 2.9 ± 0.1 dCDP/F3Y
• with k1 and k2 of 3 ± 1 s
−1 and
0.08 ± 0.01 s−1, respectively (Table 1). A1 and k1 for dCDP
formation are very similar to the amplitude and rate constant
measured for Y356
• formation by RFQ-EPR spectroscopy at the
same temperature (Figure 4A). These data suggest that Y356
•
is kinetically and chemically competent for dCDP formation
and accumulates during reverse RT. Similar to our observations
at 25 °C, k2 of 0.08 s
−1 for dCDP formation is similar to kapp of
0.06 s−1 for reoxidation of F3Y by Y356
• (Figure 4A).
The RCQ data were also analyzed relative to α2 to show that
2.7 ± 0.1 dCDPs/α2 are generated. DeoxyCDP formation was
monitored for a total of 20 min, and in contrast to the 25 °C data,
no third kinetic phase associated with cytosine was observed.
Kinetics in the Presence of a Reducing System. EPR
Analysis of Y356
• Concentration During Steady-State Turn-
over. The ability of F3Y
•-β2 to perform multiple turnovers in
the absence of a reducing system (3.5 dCDP/F3Y
•, Table 1)
and the observation of a plateau phase in the RFQ-EPR kinetic
traces (Figures 3A and 4A) suggested that reverse RT is
visualized subsequent to complete oxidation of α2. Thus, we
predicted that the concentration of Y356
• would vary minimally
in the presence of the reducing system, TR/TRR/NADPH,
as oxidized α2 is re-reduced. To test this prediction, F3Y
•-β2,
wt-α2, CDP, and ATP were combined in the presence of TR/
TRR/NADPH, and samples were quenched by hand in liquid
isopentane between 20 and 90 s. In accordance with our
Figure 5. Amount of dCDP generated in the absence of a reducing
system. A theoretical maximum of 4 dCDP/α2 can be produced;
however, only 3 dCDP/α2 are routinely measured. The reaction
mixture contains only 40% active F3Y
•-β2 (Figure 2A) supporting
reorganization of active and inactive α2/F3Y
•-β2 complexes to oxidize
all α2s.
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prediction, the amount of Y356
• does not change: 0.26 to
0.28 equiv/F3Y
• at 5 °C and 0.40 to 0.46 equiv/F3Y
• at 25 °C
(Table S2). No reverse RT was visualized during the time frame
of the reaction.
Kinetics of dCDP Formation at 5 and 25 °C. The observa-
tion of Y356
• accumulation during reverse RT (Figures 3 and 4)
in the absence of a reducing system and the lack of variation in
[Y356
•] during steady-state turnover suggest that the rate-
limiting step occurs subsequent to dCDP formation and Y356
•
reformation during reverse RT. This model predicts that RCQ
experiments in the presence of the reducing system would show
a burst of dCDP representing the ﬁrst turnover followed by a
linear phase for steady-state turnover. F3Y
•-β2, wt-α2, [3H]CDP,
and ATP were mixed in the presence of TR/TRR/NADPH, and
the reaction was monitored from 5 ms to 100 s. The results of
the F3Y
•-β2 experiments, at 5 and 25 °C, are shown in Figure 6
and summarized in Table 1.
As predicted, a burst of dCDP formation is observed at both
temperatures (0.26 ± 0.05 dCDP/F3Y
• at 6 ± 3 s−1 at 5 °C and
0.40 ± 0.05 dCDP/F3Y
• at 22 ± 9 s−1 at 25 °C) followed
by a linear phase (0.20 ± 0.01 s−1 at 5 °C and 1.73 ± 0.04 s−1 at
25 °C). The large uncertainties observed in these parameters
are associated with low amounts of dCDP arising from the “two
or none” model (Figure 2A) and half-sites reactivity (Figure 2B).
Unfortunately, we are unable to increase protein concentration in
these experiments as studies with wt RNR have revealed kinetic
complexities associated with the re-reduction process11 and
potentially quaternary structure interconversions.35
The observed rate constant and amplitude for the burst phase
are within error similar to the parameters observed for Y356
•
formation (Figures 3A and 4A) and support our conclusion that
Y356
• is on-pathway for dCDP formation. These data also
correlate well with the kinetics of the ﬁrst phase measured in the
absence of TR/TRR/NADPH (0.3 dCDP/F3Y
• at 3 s−1 at 5 °C
and 0.5 dCDP/F3Y
• at 30 s−1 at 25 °C) supporting that k1 in the
absence of a reducing system and the burst phase in the
presence of TR/TRR/NADPH report on the ﬁrst turnover by
one α/F3Y
•-β pair in the α2/F3Y
•-β2 complex (Figure 2B).
Subsequent to dCDP formation and Y356
• regeneration during
reverse RT, reoxidation of F3Y and re-reduction of oxidized α2
facilitate further turnovers. We argue subsequently that the rate-
limiting step in F3Y
•-β2 is reoxidation of F3Y by Y356
•.
■ DISCUSSION
The rate-limiting protein conformational change(s) that gate(s)
E. coli class Ia RNR turnover has precluded insight into the 35 Å
forward RT, nucleotide reduction, and reverse RT processes.
Our current model for wt RNR based on studies similar to
those described herein for F3Y
•-β2 is shown in Scheme 2.
Figure 6. Kinetics of product formation in F3Y
•-β2 in the presence of TR/TRR/NADPH at (A) 25 °C and (B) 5 °C. The averages of 2−4 separate
trials are shown. Data were ﬁt to a two-phase model with the rate constants given in Table 1. The insets show dCDP formation during the ﬁrst
(A) 0.8 s and (B) 2.5 s. The burst phase represents the very ﬁrst turnover by an α/β pair. Reverse PCET regenerating F3Y
• is rate-limiting during
steady-state turnover.
Scheme 2. Kinetic Model for wt RNR in the Absence and Presence of a Reducing Systema
aThe graphic shows only the key amino acids in the PCET pathway. Rate constants are shown for the reaction at 25 °C. Y356
• cannot be visualized in
wt RNR due to the rate-limiting conformational change(s). Figure adapted from ref 11.
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Upon association of β2/α2/CDP/ATP, a conformational
change(s) (5−10 s−1, Scheme 2, step A) triggers rapid RT
into α2 and nucleotide reduction (>100 s−1, step B).12,36
DeoxyCDP formation is rate-limited by the conformational
change(s) and occurs at 5−10 s−1 as measured by RCQ
methods reported previously11 and reproduced here under the
same conditions utilized for the F3Y
•-β2 studies (Figure S4).
Subsequent to dCDP formation, reverse RT to regenerate Y122
•
is required to be downhill12 and rapid (>103 s−1, step C) as
modeled by Ge et al.11 to account for our inability to observe
Y122
• disappear and reappear during turnover (±TR/TRR/
NADPH). The physical steps in wt RNR preclude detection of
intermediates in these processes. Thus, studying the chemistry
has required engineering speciﬁc perturbations to the system
initially through site-directed mutagenesis37−40 and the use of
mechanism-based inhibitors34,41,42 and, more recently, with site-
speciﬁc incorporation of unnatural amino acids.12,13,23,24 While
with many of these approaches we were able to monitor the
disappearance of Y122
• concomitant with formation of new
radicals, in none of these cases was the catalytic cycle of RNR
completed, and no insight was obtained into reverse RT.
Our recent engineering of an orthogonal tRNA-synthetase
tRNA pair that can incorporate di- and triﬂuorotyrosines (FnY,
n = 2, 3) with a range of reduction potentials and pKa’s
in RNR19 allowed us to introduce a tunable thermodynamic
perturbation of PCET kinetics with minimal steric perturba-
tions. F3Y is predicted as ∼10 mV harder to oxidize than Y,17,43
assuming that the ﬁrst step in forward RT involves PT from the
water on the diferric cluster to F3Y
• concomitant with ET from
Y356 to F3Y
• (Figure 1). F3Y
•-β2 is capable of catalyzing multiple
turnovers but allows detection of Y356
• (±TR/TRR/NADPH)
due to perturbed reverse RT kinetics. Our current model for
F3Y
•-β2 turnover is shown in Scheme 3. The ability to accumulate
Y356
• in F3Y
•-β2 but not in wt RNR is directly related to the
diﬀerences in the rate-limiting step in the two systems.
In our model, the F3Y
•-β2/wt-α2/CDP/ATP complex under-
goes a conformational change prior to generation of Y356
• in one
α/β pair (Scheme 3, step A). The RFQ-EPR data reported in
Figures 3A and 4A provide the rate constants for this step and
suggest that F3Y
•-β2 perturbs the conformational gate relative to
the wt enzyme (20−30 vs 5−10 s−1). We expect that forward
RT into α and dCDP production (step B in Schemes 2 and 3)
occur with similar rate constants to wt RNR (>100 s−1).12,36
DeoxyCDP formation is rate-limited by the slow, conformation-
ally gated generation of Y356
• during forward RT as measured by
the ﬁrst phase in the absence of a reducing system (Figures 3B
and 4B) or the burst phase in the presence of TR/TRR/
NADPH (Figure 6) in the RCQ studies. Subsequent to product
formation, we propose that reverse RT to regenerate Y356
• is
fast12 as modeled in wt RNR where reverse RT to regenerate
Y122
• is 103 s−1. However, unlike in wt RNR, slow reoxidation of
F3Y (step C) rate-limits subsequent turnovers.
In the absence of a reducing system, the RFQ-EPR data
(Figures 3A and 4A) provide the rate constants for step C.
Upon regeneration of F3Y
•, β2 rapidly dissociates from a partially
oxidized α2, associates with a second reduced α2 and cycles
through steps A−C until all α2s are completely oxidized.44
Y356
• concentration does not vary signiﬁcantly during this time
as visualized by the plateaus in the RFQ-EPR kinetic traces
(Figures 3A and 4A). The second phase of the RCQ studies
described in Figures 3B and 4B provides the rate constants for
turnover in the absence of TR/TRR/NADPH (Scheme 3,
branch I). Altered reverse RT kinetics in F3Y
•-β2 allow us to
observe for the ﬁrst time the disappearance and reappearance of
the radical at position 122 subsequent to complete oxidation of
α2. The molecular bases for our ability to observe reverse RT are
not well-understood but are likely related to the initiating step in
the PCET process. In addition to perturbing the driving force
for RT, the ﬂuoro substitutions could alter the distance between
the phenolic oxygen and the water on the diferric cluster, thus
aﬀecting PT between the two (Figure 1). F3Y also perturbs the
pKa at position 122 compared to Y (solution pKa 6.4 vs 10).
43
Depending on the pKa of the water on the diferric cluster, the
phenolate F3Y
− could be generated instead of the anticipated
phenol F3Y.
Additional insight into the diﬀerences between wt and F3Y
•-
β2 catalysis is obtained from the amplitudes for dCDP forma-
tion in the absence of a reducing system (Table 1 and Figure S4).
In the F3Y
•-β2 system, the ﬁrst phase (0.5 dCDP/F3Y
• at 25 °C)
reports on the very ﬁrst turnover by an α/β pair (Figure 2B),
Scheme 3. Kinetic Model for F3Y
•-β2 in the Absence and Presence of a Reducing Systema
aThe ﬁgure represents a reductionist view of key amino acids in the PCET pathway. The rate constants for each step are shown in pink (25 °C), blue
(5 °C), and black (both temperatures). It is not known if the ﬁrst RT step involves PCET to generate the phenol (F3Y), as in wt RNR or ET to
generate the phenolate (F3Y
−), as in NO2Y
•-β2.
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while the second phase (2.9 dCDP/F3Y
•) reports on con-
sumption of all remaining reduced α2s, rate-limited by reverse
RT. This result is distinct from our previous11 and current
observations for wt RNR (Figure S4) where two phases are also
measured for dCDP formation. The ﬁrst phase is presumed to
report on the conformationally gated generation of 2 dCDPs by
all α2s (the experimental observation is 1.3 ± 0.2 dCDP/α2,
6 ± 1 s−1), and the second phase is interpreted to report on the
generation of 2 additional dCDPs subsequent to re-reduction
of the active site disulﬁde (the experimental observation is 1.6 ±
0.2 dCDP/α2, 0.5 ± 0.1 s−1). The variation in the amplitudes
of the two phases between wt and F3Y
•-β2 is consistent with
diﬀerent rate-limiting steps in the two systems. However, in
both cases the total number of dCDPs generated is the same:
3 dCDP/α2 (Schemes 2 and 3, branch I).
The EPR and RCQ data collected in the presence of a
reducing system also lend support to Scheme 3. In F3Y
•-β2, a
burst of dCDP formation prior to steady-state turnover is
observed. The amplitude of this phase (∼0.5 dCDP/F3Y• at
25 °C) again reﬂects that turnover occurs only on one α/β pair
prior to the rate-limiting step and is consistent with slow reverse
RT. Upon regeneration of F3Y
• after one turnover (Scheme 3,
step C), re-reduction of oxidized α2 by TR/TRR/NADPH
resets the system for additional turnovers (branch II). Y356
•
under these conditions behaves in a similar fashion to Y122
•
in wt RNR; i.e., no changes in its concentration are detected
during steady-state conditions (Table S2). Slow reoxidation of
F3Y followed by rapid re-reduction, forward RT, nucleotide
reduction, and regeneration of Y356
• (Scheme 3, steps A−C)
precludes observation of its disappearance and reappearance.
We interpret the linear phases in Figure 6A,B as representative
of the rate constants for reverse RT in the presence of a
reducing system (Scheme 3, step C) and the rate constant limits
for re-reduction of oxidized α2. Although we set a lower limit for
re-reduction from our experiments, we note that the rate constant
for this step must be relatively fast, >5−10 s−1, to account for our
inability to monitor changes in Y356
• concentration.
A comparison of the burst phase for F3Y
•-β2 and that for
wt RNR in the presence of TR/TRR/NADPH reveals distinct
behavior in the two systems (Figure 6 and Figure S5).11
Although the conformational change is rate-limiting for dCDP
formation in wt RNR, we have previously noted that the rate-
limiting step in the presence of a reducing system can switch to
re-reduction of oxidized α2 at the high protein concentrations
required for RCQ studies (10 μM).11 In wt RNR, this results
in a conformationally gated burst of 2 dCDPs by all α2s
(the experimental observation is 1.9 ± 0.1, 9 ± 2 s−1) prior to
steady-state turnover (Figure S5).11 The burst phase reﬂects
oxidation of all α2 active sites despite the presence of only 60%
active wt-β2 (1.2 Y•/β2, Figure 2A) and does not represent a
single turnover. In contrast to the wt system, we have isolated
the very ﬁrst turnover by an α2β2 complex with F3Y
•-β2 due to
rate-limiting reverse RT.
As a ﬁnal point, the rate constant measured for dCDP forma-
tion in the presence of a reducing system is 3-fold faster
that that measured in its absence (Scheme 3, branch I vs I).
A similar variation has been previously noted for dCDP forma-
tion in the wt system.11 It is possible that re-reduction of the
active site disulﬁde by the C-terminal tail (Figure 5, step B) is
reversible and only driven to completion when the TR/TRR/
NADPH system is included in the assays. However, we currently
cannot rule out other modes by which TR accelerates re-
reduction of the α2 active site.
■ CONCLUSIONS
Radical initiation in the class I RNRs is proposed to involve
long-range PCET through three pathway tyrosines.9,10,17 Using
an engineered RNR system, we have observed one of the
proposed intermediates and demonstrate for the very ﬁrst time
chemically competent reverse RT that completes the RNR
catalytic cycle. We additionally obtained insight into radical
stoichiometry within β2, half-sites reactivity, and the ability
of β2 to act catalytically during turnover. This work highlights
the utility of unnatural amino acids in engineering speciﬁc
perturbations for the study of redox active tyrosine residues in
proteins; F3Y could facilitate understanding of a number of
additional tyrosyl radical mediated metabolic processes.45−48
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(18) Wörsdorfer, B.; Conner, D. A.; Yokoyama, K.; Livada, J.;
Seyedsayamdost, M.; Jiang, W.; Silakov, A.; Stubbe, J.; Bollinger, J. M.,
Jr.; Krebs, C. J. Am. Chem. Soc. 2013, 135, 8585−93.
(19) Minnihan, E. C.; Young, D. D.; Schultz, P. G.; Stubbe, J. J. Am.
Chem. Soc. 2011, 133, 15942−5.
(20) Yokoyama, K.; Smith, A. A.; Corzilius, B.; Griffin, R. G.; Stubbe,
J. J. Am. Chem. Soc. 2011, 133, 18420−32.
(21) Seyedsayamdost, M. R.; Chan, C. T.; Mugnaini, V.; Stubbe, J.;
Bennati, M. J. Am. Chem. Soc. 2007, 129, 15748−9.
(22) Minnihan, E. C. Ph.D. Dissertation, Massachusetts Institute of
Technology, 2012.
(23) Minnihan, E. C.; Seyedsayamdost, M. R.; Uhlin, U.; Stubbe, J. J.
Am. Chem. Soc. 2011, 133, 9430−40.
(24) Seyedsayamdost, M. R.; Xie, J.; Chan, C. T.; Schultz, P. G.;
Stubbe, J. J. Am. Chem. Soc. 2007, 129, 15060−71.
(25) Chen, H.; Gollnick, P.; Phillips, R. S. Eur. J. Biochem. 1995, 229,
540−9.
(26) Seyedsayamdost, M. R.; Yee, C. S.; Stubbe, J. Nat. Protoc. 2007,
2, 1225−35.
(27) Chivers, P. T.; Prehoda, K. E.; Volkman, B. F.; Kim, B. M.;
Markley, J. L.; Raines, R. T. Biochemistry 1997, 36, 14985−91.
(28) Russel, M.; Model, P. J. Bacteriol. 1985, 163, 238−242.
(29) Palmer, G. Methods Enzymol. 1967, 10, 594−610.
(30) Steeper, J. R.; Steuart, C. D. Anal. Biochem. 1970, 34, 123−30.
(31) Tong, W. H.; Chen, S.; Lloyd, S. G.; Edmondson, D. E.; Huynh,
B. H.; Stubbe, J. J. Am. Chem. Soc. 1996, 118, 2107−8.
(32) Bennati, M.; Weber, A.; Antonic, J.; Perlstein, D. L.; Robblee, J.
H.; Stubbe, J. J. Am. Chem. Soc. 2003, 125, 14988−9.
(33) Bennati, M.; Robblee, J. H.; Mugnaini, V.; Stubbe, J.; Freed, J.
H.; Borbat, P. J. Am. Chem. Soc. 2005, 127, 15014−5.
(34) Ator, M. A.; Stubbe, J. Biochemistry 1985, 24, 7214−21.
(35) Ando, N.; Brignole, E. J.; Zimanyi, C. M.; Funk, M. A.;
Yokoyama, K.; Asturias, F. J.; Stubbe, J.; Drennan, C. L. Proc. Natl.
Acad. Sci. U. S. A. 2011, 108, 21046−51.
(36) Olshansky, L.; Pizano, A. A.; Wei, Y.; Stubbe, J.; Nocera, D. G. J.
Am. Chem. Soc. 2014, 136, 16210−6.
(37) Lawrence, C. C.; Bennati, M.; Obias, H. V.; Bar, G.; Griffin, R.
G.; Stubbe, J. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 8979−84.
(38) Mao, S. S.; Holler, T. P.; Yu, G. X.; Bollinger, J. M., Jr.; Booker,
S.; Johnston, M. I.; Stubbe, J. Biochemistry 1992, 31, 9733−43.
(39) Persson, A. L.; Eriksson, M.; Katterle, B.; Pötsch, S.; Sahlin, M.;
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